|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 599.21 USD | +0.71% |
|
+2.11% | +6.69% |
| Capitalization | 16.88B 14.45B 13.44B 12.53B 23.41B 1,521B 25.11B 155B 60.86B 728B 63.3B 62B 2,668B | P/E ratio 2025 * |
40.5x | P/E ratio 2026 * | 36.3x |
|---|---|---|---|---|---|
| Enterprise value | 16.47B 14.11B 13.12B 12.23B 22.85B 1,485B 24.51B 151B 59.41B 710B 61.78B 60.52B 2,605B | EV / Sales 2025 * |
6.56x | EV / Sales 2026 * | 5.62x |
| Free-Float |
83.69% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: Medpace Holdings, Inc.
| 1 day | +0.71% | ||
| 1 week | +2.11% | ||
| Current month | +6.69% | ||
| 1 month | +7.40% | ||
| 3 months | +19.55% | ||
| 6 months | +85.23% | ||
| Current year | +6.69% |
| 1 week | 591.03 |  | 614.36 |
| 1 month | 544.24 | | 614.36 |
| Current year | 551 | | 614.36 |
| 1 year | 250.05 | | 626.26 |
| 3 years | 167 | | 626.26 |
| 5 years | 126.94 | | 626.26 |
| 10 years | 21.76 | | 626.26 |
| Manager | Title | Age | Since |
|---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 69 | 01/07/1992 |
Kevin Brady
DFI | Director of Finance/CFO | 51 | 01/08/2021 |
Jesse Geiger
PSD | President | 51 | 01/08/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
August Troendle
CHM | Chairman | 69 | 01/07/1992 |
Robert Kraft
BRD | Director/Board Member | 55 | 01/07/2016 |
Brian Carley
BRD | Director/Board Member | 72 | 01/07/2016 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.71% | +2.11% | +70.78% | +165.23% | 16.88B | |
| +0.25% | +5.60% | +3.89% | +15.97% | 49.9B | |
| -0.64% | +2.67% | +18.49% | +9.73% | 41.02B | |
| -1.15% | +4.27% | +89.00% | +26.88% | 36.96B | |
| +1.88% | +7.16% | +21.92% | +42.32% | 31.91B | |
| -1.24% | +49.59% | +180.45% | +292.00% | 22.65B | |
| -3.67% | +63.13% | +34,577.67% | +5,582.08% | 21.81B | |
| +2.62% | +9.29% | +49.72% | +13.52% | 14.8B | |
| -0.68% | -8.82% | -17.45% | -19.09% | 13.76B | |
| +1.69% | +3.99% | +144.05% | +109.22% | 13.23B | |
| Average | +0.47% | +13.30% | +3,513.85% | +623.79% | 26.29B | |
| Weighted average by Cap. | +0.24% | +12.29% | +2,916.69% | +517.60% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 2.51B 2.15B 2B 1.86B 3.48B 226B 3.74B 23.04B 9.06B 108B 9.42B 9.22B 397B | 2.81B 2.41B 2.24B 2.09B 3.9B 254B 4.19B 25.81B 10.14B 121B 10.55B 10.33B 445B |
| Net income | 436M 373M 347M 324M 605M 39.31B 649M 4B 1.57B 18.81B 1.64B 1.6B 68.95B | 479M 411M 382M 356M 665M 43.21B 713M 4.4B 1.73B 20.67B 1.8B 1.76B 75.8B |
| Net Debt | -404M -346M -322M -300M -561M -36.43B -601M -3.71B -1.46B -17.43B -1.52B -1.48B -63.9B | -1.06B -908M -845M -788M -1.47B -95.61B -1.58B -9.73B -3.83B -45.74B -3.98B -3.9B -168B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/01/26 | 599.21 $ | +0.71% | 274,566 |
| 09/01/26 | 595.00 $ | -0.84% | 189,214 |
| 08/01/26 | 600.02 $ | -2.13% | 235,707 |
| 07/01/26 | 613.09 $ | +0.69% | 234,262 |
| 06/01/26 | 608.89 $ | +3.76% | 206,726 |
Delayed Quote Nasdaq, 13 January 2026 at 08:00 am AEDT
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MEDP Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition